Literature DB >> 647014

Molecular data on urinary glycoproteins with human leucocyte antigen (HLA) activity.

I Bernier, A Dautigny, J Jollès, J Colombani, P Jollès.   

Abstract

Two glycoproteins characterized by their serological activities (HLA-A9 and HLA-B12), their isoelectric points and their molecular weights were purified from urine from a patient suffering from tubular proteinuria (cystinosis). Their physicochemical properties as well as an important increase of their specific activities during the different purification steps suggested that they behave as human leucocyte antigens (HLA) which had been excreted into urine. Their amino acid compositions and N-terminal sequences were different to those described for HLA solubilized from cultured human lymphoblast cell lines. The N-terminal sequences of the two serologically active glycoproteins were identical to the N-terminal sequence of another recently purified human urinary glycoprotein called human complex-forming glycoprotein. The relationship between HLA, human complex-forming glycoprotein and the serologically active urinary glycoproteins is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 647014     DOI: 10.1016/0005-2795(78)90381-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Characterization of alpha 1-microglobulin in human colostrum and milk.

Authors:  I Bernier; A Dautigny; P Jollès
Journal:  Experientia       Date:  1980-12-15

2.  Localization of alpha 1-microglobulin (HC protein) in normal human tissues: an immunohistochemical study using monoclonal antibodies.

Authors:  P Bouic; C Vincent; J P Revillard
Journal:  Histochem J       Date:  1984-12

3.  Synthesis and secretion of alpha 1-microglobulin by human lymphocytes.

Authors:  Y Itoh; K Kin; T Kasahara; I Sakurabayashi; T Kawai; K Shiori-Nakano; K Takagi
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

4.  Tissue distribution of human alpha1-microglobulin.

Authors:  K Takagi; K Kin; Y Itoh; T Kawai; T Kasahara; T Shimoda; T Shikata
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.